NCT02250443
- Conditions
- Muscular Diseases, Musculoskeletal Diseases, Myositis, +4 more
- Locations
-
- Novartis Investigative Site Phoenix, Arizona, United States
- Novartis Investigative Site Boston, Massachusetts, United States
Clinical trial condition
Explore clinical trials studying Sporadic Inclusion Body Myositis (sIBM). Study availability and eligibility vary by location and protocol.
NCT02250443